THERAPEUTIC PRODUCT EFFECT PROLONGED

This adverse event was reported 453 times

These drugs are most commonly taken by patients reporting THERAPEUTIC PRODUCT EFFECT PROLONGED:

# Drug Count
0 SODIUM OXYBATE 58
1 ROCURONIUM BROMIDE 20
2 ROPIVACAINE HYDROCHLORIDE 20
3 BUPIVACAINE 18
4 ERGOCALCIFEROL 17
5 SILDENAFIL CITRATE 17
6 DOXYLAMINE SUCCINATE 15
7 ONDANSETRON HYDROCHLORIDE 15
8 GABAPENTIN 14
9 OSILODROSTAT 14
See all common drugs associated with THERAPEUTIC PRODUCT EFFECT PROLONGED

THERAPEUTIC PRODUCT EFFECT PROLONGED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PAFOLACIANINE INJECTION 1 0.0159
1 ARTICAINE HYDROCHLORIDE AND EPINEPHRINE BITARTRATE 8 0.0135
2 ROPIVACAINE HYDROCHLORIDE 20 0.0082
3 NEOSTIGMINE METHYLSULFATE 3 0.0070
4 SODIUM PICOSULFATE, MAGNESIUM OXIDE, AND ANHYDROUS CITRIC ACID 5 0.0069
5 OSILODROSTAT 14 0.0063
6 BREMELANOTIDE 6 0.0052
7 SOLRIAMFETOL 11 0.0029
8 PITOLISANT HYDROCHLORIDE 6 0.0028
9 SUCCINYLCHOLINE CHLORIDE 6 0.0027
See all drugs enriched for association with THERAPEUTIC PRODUCT EFFECT PROLONGED